AXEVIL Capital

Decagon Stock Price, Valuation & IPO

Private company — Decagon is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.

Status source: AXEVIL investment team

$34.85 per share (AXEVIL consensus estimate)

Source: AXEVIL consensus of recent secondary transactions · as of 27 October 2026

Last round valuation: $4.5B

Source: D, January 2026, post-money

Total raised: $481M

Data last updated: 27 October 2026

About Decagon

AI-agent platform automating customer support and service in a concierge-style experience. Raised $250M in January 2026 at a $4.5B valuation, tripling its value from $1.5B in June 2025. Annual revenue was estimated around $35M in fall 2025, growing more than 3x year over year.

Decagon builds software agents that talk to a company's customers themselves — in chat, email, and by phone — and carry a request through to resolution. Founded in August 2023. The fundamental difference from earlier systems is that the agent does not reply with canned phrases but performs actions inside the customer's systems: finds an order, processes a return, changes a subscription. The market the company targets holds roughly 17 million contact-center agents by Gartner's estimate, most of them working on phone calls specifically. In June 2026 it opened a London hub with a staff of more than 50. Current valuation is $4.5B from a $250M Series D (January 2026), against $1.5B in June 2025; $481M raised.

  • Sector: AI / Enterprise
  • Headquarters: San Francisco, USA
  • Founded: 2023

Key highlights

  1. The valuation tripled in seven months — the market is repricing the category before your eyes. In June 2025 the company was worth $1.5B; by January 2026 it was $4.5B after a $250M round led by Coatue and Index Ventures.
  2. The voice segment opens a budget four times larger than chat. Most of the 17 million contact-center agents Gartner counts are occupied with phone conversations specifically.
  3. International expansion began in June 2026 and is already confirmed by customers. The company opened a London hub with a staff of more than 50, citing demand in Europe and the Middle East as the reason.
  4. Liquidity for employees has already been created — the company is not obliged to rush to a listing. The first share buyback took place in March 2026.
  5. Sierra's example shows the upper bound of where the category can go. Founded in the same year, 2023, Sierra had reached $200M of annual revenue and a $15.8B valuation by May 2026.

Funding rounds

DateRoundPrice / sharePost-money valuation
28 January 2026D$32.07$4.5B
23 June 2025C$12.66$1.5B
5 October 2024B$6.01$650M
18 June 2024A$1.70$184M

Latest news

Frequently asked questions

How can I buy Decagon stock before the IPO?

Not on a public exchange — Decagon is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.

What is the Decagon stock price?

A private company has no single official share price. AXEVIL's consensus estimate is $34.85 per share as of 27 October 2026. Its most recent round implied a post-money valuation of $4.5B (January 2026).

What is Decagon's valuation (net worth)?

Decagon's most recent funding round valued the company at $4.5B post-money (January 2026) — the latest primary-market measure of what the company is worth. Secondary trades can price its shares above or below that round.

When will Decagon IPO?

No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.

Is Decagon publicly traded?

No. Decagon is a private company and its shares are not listed on any public exchange.

Does Decagon have a stock symbol?

No. Decagon has no ticker symbol because its shares are not listed on any exchange; a symbol is assigned only at an IPO or direct listing.

Similar companies

Risk disclosure

Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.

Full legal disclosures · All companies